HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: fj.06-7366lsfv1 21/9/2014    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Liu, L. Articles by Mason, R. P. Search for Related Content PubMed PubMed Citation Articles by Liu, L. Articles by Mason, R. P.

¹⁹F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl ß-D-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse ¹

Department of Radiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA

²Correspondence: Department of Radiology, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, Texas 75390-9058, USA. E-mail: ralph.mason{at}utsouthwestern.edu

Gene therapy shows promise for treating prostate cancer and has been evaluated in several clinical trials. A major challenge that remains is to establish a method for verifying transgene activity in situ. The lacZ gene encoding ß-galactosidase historically has been the most popular reporter gene for molecular biology. We have designed a ¹⁹F NMR approach to reveal lacZ gene expression by assessing ß-galactosidase (ß-gal) activity in vivo. The substrate 2-fluoro-4-nitrophenyl ß-D-galactopyranoside (OFPNPG) is readily hydrolyzed by ß-gal with a corresponding decrease in the ¹⁹F-NMR signal from OFPNPG and the appearance of a new signal shifted 4–6 ppm upfield from the aglycone 2-fluoro-4-nitrophenol (OFPNP). We report proof of principle in cultures of PC3 prostate cancer cells using ¹⁹F NMR spectroscopy and ¹⁹F chemical shift imaging. More importantly, we demonstrate for the first time the ability to differentiate wild-type and lacZ-expressing prostate tumor xenografts in mice using this approach.—Liu, L., Kodibagkar, V. D., Yu, J-X., Mason, R. P. ¹⁹F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl ß-D-galactopyranoside in vivo in PC3 prostate tumor.

Key Words: ß-galactosidase • ¹⁹F CSI • ¹⁹F MRS • gene reporter